NASDAQ · Drug Manufacturers - Specialty & Generic
Shuttle Pharmaceuticals Inc (SHPH)
$3.53
0.00%
Moving averages
SMA 200$11.27-68.68%
Company profile
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$2.38M
P/E ratio40.7
EPS$0.10
Beta1.223
Dividend yield0.00%
52-week high$55.90
52-week low$2.58
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 43
CGC
Canopy Growth Corporation
RSI 36
BFRI
Biofrontera Inc
RSI 60
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 43
ACB
Aurora Cannabis Inc
RSI 53
BCRX
Biocryst Pharmaceuticals Inc
RSI 30
INM
InMed Pharmaceuticals Inc
RSI 37
ORGO
Organogenesis Holdings Inc - Class A
RSI 29
ZTS
Zoetis Inc - Class A
RSI 57
RSI alerts for SHPH
Get an email the moment Shuttle Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 2:29 AM EDT